Get started
Author

Fabiana Pancani

CEBPA –double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
2016 · Francesco Mannelli, Vanessa Ponziani, et al. · Haematologica · 73
PDF
The prognostic contribution of CBL , NRAS , KRAS , RUNX1 , and TP53 mutations to mutation‐enhanced international prognostic score systems ( MIPSS70 /plus/plus v2.0) for primary myelofibrosis
2023 · Giuseppe G. Loscocco, Giada Rotunno, et al. · American Journal of Hematology · 36
PDF
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience
2021 · Matteo Piccini, Sofia Pilerci, et al. · Journal of Clinical Medicine · 34
PDF
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis
2022 · Giacomo Coltro, Francesco Mannelli, et al. · Blood Cancer Journal · 28
PDF
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia
2014 · Francesco Mannelli, Ilaria Cutini, et al. · Cytometry Part B Clinical Cytometry · 23
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates
2022 · Giuseppe G. Loscocco, Paola Guglielmelli, et al. · American Journal of Hematology · 14
PDF
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia
2014 · Francesco Mannelli, Ilaria Cutini, et al. · Cytometry Part B Clinical Cytometry · 13
JAK2V617F Molecular Response to Ruxolitinib in Patients with PV and ET Is Associated with Lower Risk of Progression to Secondary Myelofibrosis
2022 · Paola Guglielmelli, Barbara Mora, et al. · Blood · 8
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia
2023 · Francesco Mannelli, Matteo Piccini, et al. · Haematologica · 6
PDF
A Myelodepletive Phenotype Is Associated with Distinctive Molecular Features and Adverse Outcomes in Patients with Myelofibrosis
2021 · Giacomo Coltro, Francesco Mannelli, et al. · Blood · 6
Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category
2020 · Francesco Mannelli, Sara Bencini, et al. · Cancers · 5
PDF
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia
2015 · Francesco Mannelli, Vanessa Ponziani, et al. · Experimental Hematology · 5
Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Single-Centre Experience
2022 · Matteo Piccini, Sofia Pilerci, et al. · Blood · 3
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia
2020 · Francesco Mannelli, Giacomo Gianfaldoni, et al. · American Journal of Hematology · 3
PDF
Changes in neutrophil-to-lymphocyte ratio in patients with polycythemia vera treated with ruxolitinib reflect JAK2 variant allele frequency
2026 · Paola Guglielmelli, Chiara Paoli, et al. · Haematologica · 2
PDF
Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML
2025 · Francesco Mannelli, Matteo Piccini, et al. · Blood Cancer Journal · 2
APL-like Subset within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating with Early-Onset Vascular Complications
2023 · Francesca Crupi, Gaia Ciolli, et al. · Blood · 2
PDF
APL‐like subset within NPM1 ‐mutated AML: A distinct immunophenotype correlating with early vascular complications
2026 · Francesco Mannelli, Francesca Crupi, et al. · HemaSphere · 1
Changes in neutrophil-to-lymphocyte ratio (NLR) in patients with polycythemia vera treated with ruxolitinib reflect changes of JAK2 variant allele frequency (VAF)
2025 · Chiara Paoli, Paola Guglielmelli, et al. · Blood · 1
Third Generation Sequencing of Normal Karyotype Acute Myeloid Leukemia: Implications for Prognosis
2019 · Niccolò Bartalucci, Francesco Mannelli, et al. · Florence Research (University of Florence) · 1
Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia
2026 · Matteo Piccini, Naseema Gangat, et al. · American Journal of Hematology
PDF
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting
2024 · Gaia Ciolli, Matteo Piccini, et al. · Haematologica
PDF
The Impact of Baseline Genetic Profile and Treatment on Hematological Toxicity in CEBPA-Mutated Acute Myeloid Leukemia
2023 · Francesco Mannelli, Matteo Piccini, et al. · Blood
PDF
AML-251 APL-Like Subset Within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating With Early-Onset Vascular Complications
2023 · Gaia Ciolli, Francesca Crupi, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
POSTER: AML-251 APL-Like Subset Within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating With Early-Onset Vascular Complications
2023 · Gaia Ciolli, Francesca Crupi, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
Works count: 32
Citation count: 266
H-index: 8
I10-index: 7
Year
Topic
Type